Quoted...

Quoted from

http://seekingalpha.com/article/187575-chemgenex-a-snow-fueled-setback-at-the-fda?source=from_friend

"Negative comments from FDA reviewers coupled with snow in Washington have changed the game for the first-in-class chronic myeloid leukaemia (CML) treatment, and with it, ChemGenex Pharmaceuticals (CXSPY.PK) market fortunes."

Does anybody know what the exact wordings were of these negative comments?

Thanks from David